Furukawa T - Search Results

1

Docetaxel enhances the cytotoxicity of anthracyclines by increasing intracellular drug accumulation.

Egawa T, Kubota T, Suto A, Otani Y, Furukawa T, Watanabe M, Kumai K, Kitajima M. Egawa T, et al. Among authors: furukawa t. Oncol Rep. 2002 Jul-Aug;9(4):777-81. Oncol Rep. 2002. PMID: 12066208

2

Antitumor activity of doxorubicin in combination with docetaxel against human breast cancer xenografts.

Egawa T, Kubota T, Suto A, Otani Y, Furukawa T, Saikawa Y, Watanabe M, Kumai K, Kitajima M. Egawa T, et al. Among authors: furukawa t. In Vivo. 2003 Jan-Feb;17(1):23-8. In Vivo. 2003. PMID: 12655785

3

No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay.

Maeda S, Saikawa Y, Kubota T, Aoki M, Otani Y, Furukawa T, Watanabe M, Kumai K, Kitajima M. Maeda S, et al. Among authors: furukawa t. Anticancer Res. 2003 Jul-Aug;23(4):3147-50. Anticancer Res. 2003. PMID: 12926047

4

Chemosensitivity testing--present and future in Japan.

Kubota T, Otani Y, Furukawa T, Hasegawa H, Watanabe M, Kitajima M. Kubota T, et al. Among authors: furukawa t. Recent Results Cancer Res. 2003;161:231-41. doi: 10.1007/978-3-642-19022-3_18. Recent Results Cancer Res. 2003. PMID: 12528811

5

Clinical usefulness of chemosensitivity test for advanced colorectal cancer.

Kabeshima Y, Kubota T, Watanabe M, Hasegawa H, Furukawa T, Kitajima M. Kabeshima Y, et al. Among authors: furukawa t. Anticancer Res. 2002 Sep-Oct;22(5):3033-7. Anticancer Res. 2002. PMID: 12530038

6

Independent antitumor spectrum of UCN-01 (7-hydroxystaurosporine) against gastric and colorectal cancers as detected by MTT assay.

Abe S, Kubota T, Saikawa Y, Otani Y, Furukawa T, Watanabe M, Kumai K, Kitajima M. Abe S, et al. Among authors: furukawa t. Anticancer Res. 2002 Nov-Dec;22(6B):3605-10. Anticancer Res. 2002. PMID: 12552963

7

Cancer chemotherapy chemosensitivity testing is useful in evaluating the appropriate adjuvant cancer chemotherapy for stages III/IV gastric cancers without peritoneal dissemination.

Kubota T, Egawa T, Otani Y, Furukawa T, Saikawa Y, Yoshida M, Watanabe M, Kumai K, Kitajima M. Kubota T, et al. Among authors: furukawa t. Anticancer Res. 2003 Jan-Feb;23(1B):583-7. Anticancer Res. 2003. PMID: 12680150

8

[Standardization of cancer treatment and legal medical standards].

Furukawa T, Kitajima M. Furukawa T, et al. Nihon Geka Gakkai Zasshi. 2003 May;104(5):380-5. Nihon Geka Gakkai Zasshi. 2003. PMID: 12774520 Japanese.

9

Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray.

Suganuma K, Kubota T, Saikawa Y, Abe S, Otani Y, Furukawa T, Kumai K, Hasegawa H, Watanabe M, Kitajima M, Nakayama H, Okabe H. Suganuma K, et al. Among authors: furukawa t. Cancer Sci. 2003 Apr;94(4):355-9. doi: 10.1111/j.1349-7006.2003.tb01446.x. Cancer Sci. 2003. PMID: 12824904 Free PMC article.

10

Reduced angiogenesis in peritoneal dissemination of gastric cancer through gelatinase inhibition.

Wada N, Otani Y, Kubota T, Kimata M, Minagawa A, Yoshimizu N, Kameyama K, Saikawa Y, Yoshida M, Furukawa T, Fujii M, Kumai K, Okada Y, Kitajima M. Wada N, et al. Among authors: furukawa t. Clin Exp Metastasis. 2003;20(5):431-5. doi: 10.1023/a:1025453500148. Clin Exp Metastasis. 2003. PMID: 14524532

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,873 results

Search Page

Filters